Anfield Capital Management, LLC Laboratory Corp Of America Holdings Transaction History

Anfield Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	SELL	$203.72 - $248.97 $122,639 - $149,879	-602 Reduced 69.84%	260 $61,000
Q3 2022 Nov 09, 2022	BUY	$204.81 - $262.19 $5,529 - $7,079	27 Added 3.23%	862 $177,000
Q2 2022 Aug 09, 2022	BUY	$213.86 - $277.87 $38,922 - $50,572	182 Added 27.87%	835 $196,000
Q1 2022 May 13, 2022	BUY	$259.82 - $298.18 $125,233 - $143,722	482 Added 281.87%	653 $172,000
Q4 2021 Feb 03, 2022	BUY	$271.6 - $314.21 $42,369 - $49,016	156 Added 1040.0%	171 $54,000
Q3 2021 Nov 04, 2021	BUY	$274.82 - $308.34 $4,122 - $4,625	15 New	15 $4,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Anfield Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Anfield Capital Management, LLC with notifications on news.